When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of the human body , weight regulation, by: reducing appetite and consequently energy intake , increasing energy expenditure , redirecting nutrients from adipose to lean ...

3. Novo's older obesity drug is safe and effective for children ...

   www.aol.com/news/novos-older-obesity-drug-safe...

   Novo Nordisk's older weight-loss drug Saxenda helped children between the ages of 6 and under 12 reduce their body mass index by 7.4% in a 56-week trial, according to results presented at a ...

4. Medicare can pay for obesity drugs like Wegovy in certain ...

   www.aol.com/news/medicare-pay-obesity-drugs...

   March 21, 2024 at 4:41 PM. Medicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future heart attacks ...

5. Eli Lilly obesity drug now available in US pharmacies - AOL

   www.aol.com/news/eli-lillys-obesity-drug-now...

   Wall Street analysts expect sales of Zepbound to reach about $2 billion in 2024, and for sales of Novo Nordisk's rival obesity drug Wegovy to hit around $7.5 billion. Pfizer last week said it ...

6. Semaglutide - Wikipedia

   en.wikipedia.org/wiki/Semaglutide

   Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. [19] [20] [21] It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. [22] [23] It can be administered by subcutaneous injection or taken orally.

7. Cagrilintide/semaglutide - Wikipedia

   en.wikipedia.org/wiki/Cagrilintide/semaglutide

   It is injected once weekly and is being tested in type 2 diabetes and obesity. Preliminary trial results found a greater weight loss compared to either medication alone. HbA1c was significantly improved compared to cagrilintide alone and non-significantly better than semaglutide alone.